Continuity Biosciences, LLC — Form D
Continuity Biosciences, LLC of BRADENTON, FL, a company, filed a Form D exempt-offering notice with the SEC on 2025-06-04. The offering totals $1.0M, of which $1.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-06-04
- Form: D
- Accession: 0002029079-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $1.0M
- Investors: 13
- Date of first sale: 2025-05-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-548002
Issuer
- Name: Continuity Biosciences, LLC
- CIK: 0002029079
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 8476 LINDRICK LANE, BRADENTON, FL, 34202
- Phone: 919-480-3892
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Michael L Fowler | Director | Bradenton, FL |
| Monica P Reed | Director | Bradenton, FL |
| Joseph R DeSimone | Director | Bradenton, FL |
| Ramakrishna Venugopalan | Director | Bradenton, FL |
| Ramakrishna Venugopalan | Executive Officer | Bradenton, FL |
| Robert Whitehead | Director | Bradenton, FL |
| Robert Whitehead | Executive Officer | Bradenton, FL |
| Josephine R Torrente | Director | Bradenton, FL |
| Allen R Weiss | Director | Orlando, FL |
Other filings by this issuer (2)
More